112 related articles for article (PubMed ID: 1611016)
21. Vasoconstrictor responsiveness of the rat mesenteric arterial bed in cirrhosis.
Ralevic V; Mathie RT; Moore KP; Burnstock G
Br J Pharmacol; 1996 May; 118(2):435-41. PubMed ID: 8735649
[TBL] [Abstract][Full Text] [Related]
22. In micronodular cirrhosis, hepatocytes retain a normal C-25 hydroxylation capacity toward vitamin D3: a study using the rat carbon tetrachloride-induced cirrhotic model.
Dubé C; Vallières S; Ethier C; Benbrahim N; Tremblay C; Gascon-Barré M
Hepatology; 1991 Mar; 13(3):489-99. PubMed ID: 1847894
[TBL] [Abstract][Full Text] [Related]
23. In vivo gene transfer of endothelial nitric oxide synthase decreases portal pressure in anaesthetised carbon tetrachloride cirrhotic rats.
Van de Casteele M; Omasta A; Janssens S; Roskams T; Desmet V; Nevens F; Fevery J
Gut; 2002 Sep; 51(3):440-5. PubMed ID: 12171971
[TBL] [Abstract][Full Text] [Related]
24. Tolerance of the cirrhotic liver to cold ischemia: ex vivo analysis in rats.
Kishikawa K; Yanaga K; Kakizoe S; Suehiro T; Sugimachi K
Eur Surg Res; 1996; 28(2):111-8. PubMed ID: 8834368
[TBL] [Abstract][Full Text] [Related]
25. Superoxide dismutase gene transfer reduces portal pressure in CCl4 cirrhotic rats with portal hypertension.
Laviña B; Gracia-Sancho J; Rodríguez-Vilarrupla A; Chu Y; Heistad DD; Bosch J; García-Pagán JC
Gut; 2009 Jan; 58(1):118-25. PubMed ID: 18829979
[TBL] [Abstract][Full Text] [Related]
26. Mixed endothelin receptor antagonist, SB209670, decreases portal pressure in biliary cirrhotic rats in vivo by reducing portal venous system resistance.
Kojima H; Yamao J; Tsujimoto T; Uemura M; Takaya A; Fukui H
J Hepatol; 2000 Jan; 32(1):43-50. PubMed ID: 10673066
[TBL] [Abstract][Full Text] [Related]
27. Role of hepatic artery in haemodynamics in normal and cirrhotic livers in rats.
Shibayama Y; Nakata K
J Gastroenterol Hepatol; 1991; 6(6):591-4. PubMed ID: 1782375
[TBL] [Abstract][Full Text] [Related]
28. Significance of hepatic arterial responsiveness for adequate tissue oxygenation upon portal vein occlusion in cirrhotic livers.
Mücke I; Richter S; Menger MD; Vollmar B
Int J Colorectal Dis; 2000 Nov; 15(5-6):335-41. PubMed ID: 11151440
[TBL] [Abstract][Full Text] [Related]
29. [Changes in humoral substances in induced cirrhosis and their effects on portal hemodynamics].
Li XN
Zhonghua Wai Ke Za Zhi; 1989 Aug; 27(8):489-94, 510. PubMed ID: 2575972
[TBL] [Abstract][Full Text] [Related]
30. Role of gap junctions modulating hepatic vascular tone in cirrhosis.
Hernández-Guerra M; González-Méndez Y; de Ganzo ZA; Salido E; García-Pagán JC; Abrante B; Malagón AM; Bosch J; Quintero E
Liver Int; 2014 Jul; 34(6):859-68. PubMed ID: 24350605
[TBL] [Abstract][Full Text] [Related]
31. Nitroflurbiprofen, a nitric oxide-releasing cyclooxygenase inhibitor, improves cirrhotic portal hypertension in rats.
Laleman W; Van Landeghem L; Van der Elst I; Zeegers M; Fevery J; Nevens F
Gastroenterology; 2007 Feb; 132(2):709-19. PubMed ID: 17258737
[TBL] [Abstract][Full Text] [Related]
32. Hepatic artery and portal vein vascularization of normal and cirrhotic rat liver.
Kassissia I; Brault A; Huet PM
Hepatology; 1994 May; 19(5):1189-97. PubMed ID: 8175141
[TBL] [Abstract][Full Text] [Related]
33. Endothelin induced contractility of stellate cells from normal and cirrhotic rat liver: implications for regulation of portal pressure and resistance.
Rockey DC; Weisiger RA
Hepatology; 1996 Jul; 24(1):233-40. PubMed ID: 8707268
[TBL] [Abstract][Full Text] [Related]
34. Changes of blood humoral substances in experimental cirrhosis and their effects on portal hemodynamics.
Li XN; Huang CT; Wang XH; Leng XS; Du RY; Chen YF; Hou X
Chin Med J (Engl); 1990 Dec; 103(12):970-7. PubMed ID: 2127249
[TBL] [Abstract][Full Text] [Related]
35. Increased hepatic platelet activating factor (PAF) and PAF receptors in carbon tetrachloride induced liver cirrhosis.
Yang Y; Nemoto EM; Harvey SA; Subbotin VM; Gandhi CR
Gut; 2004 Jun; 53(6):877-83. PubMed ID: 15138217
[TBL] [Abstract][Full Text] [Related]
36. Increased blood flow through the portal system in cirrhotic rats.
Vorobioff J; Bredfeldt JE; Groszmann RJ
Gastroenterology; 1984 Nov; 87(5):1120-6. PubMed ID: 6479534
[TBL] [Abstract][Full Text] [Related]
37. [Influence of platelet activating factor and its antagonist on portal hypertension associated with liver cirrhosis: an experiment with rats].
Wang CP; Han J; Ma XM; Dong K; Xiang Y; Su SH; Feng YY; Yang YP
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(47):3337-41. PubMed ID: 16409839
[TBL] [Abstract][Full Text] [Related]
38. An isolated dual-perfused rabbit liver preparation for the study of hepatic blood flow regulation.
Alexander B; Mathie RT; Ralevic V; Burnstock G
J Pharmacol Toxicol Methods; 1992 Mar; 27(1):17-22. PubMed ID: 1581609
[TBL] [Abstract][Full Text] [Related]
39. Pressor response to a postural change in cirrhosis: an experimental study in the CCl4-treated rat.
Bomzon A; Weinbroum A; Blendis LM
Clin Sci (Lond); 1992 Feb; 82(2):147-56. PubMed ID: 1311652
[TBL] [Abstract][Full Text] [Related]
40. The third gas: H2S regulates perfusion pressure in both the isolated and perfused normal rat liver and in cirrhosis.
Fiorucci S; Antonelli E; Mencarelli A; Orlandi S; Renga B; Rizzo G; Distrutti E; Shah V; Morelli A
Hepatology; 2005 Sep; 42(3):539-48. PubMed ID: 16108046
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
